These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 24418215)

  • 21. The value of irbesartan in the management of hypertension.
    Bramlage P; Durand-Zaleski I; Desai N; Pirk O; Hacker C
    Expert Opin Pharmacother; 2009 Aug; 10(11):1817-31. PubMed ID: 19601700
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Protective effects of aliskiren and valsartan in mice with diabetic nephropathy.
    Wang W; Qiu L; Howard A; Solis N; Li C; Wang X; Kopp JB; Levi M
    J Renin Angiotensin Aldosterone Syst; 2014 Dec; 15(4):384-95. PubMed ID: 25031296
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Systemic and local effects of angiotensin II blockade in experimental diabetic nephropathy.
    Vieitez P; Gómez O; Uceda ER; Vera ME; Molina-Holgado E
    J Renin Angiotensin Aldosterone Syst; 2008 Jun; 9(2):96-102. PubMed ID: 18584585
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Renal responses to three types of renin-angiotensin system blockers in patients with diabetes mellitus on a high-salt diet: a need for higher doses in diabetic patients?
    Hollenberg NK; Fisher ND; Nussberger J; Moukarbel GV; Barkoudah E; Danser AH
    J Hypertens; 2011 Dec; 29(12):2454-61. PubMed ID: 22002336
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Irbesartan lowers blood pressure and ameliorates renal injury in experimental non-insulin-dependent diabetes mellitus.
    O'Donnell MP; Crary GS; Oda H; Kasiske BL; Powell JR; Keane WF
    Kidney Int Suppl; 1997 Dec; 63():S218-20. PubMed ID: 9407464
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fatty Acid-Binding Protein 4 mediates apoptosis via endoplasmic reticulum stress in mesangial cells of diabetic nephropathy.
    Yao F; Li Z; Ehara T; Yang L; Wang D; Feng L; Zhang Y; Wang K; Shi Y; Duan H; Zhang L
    Mol Cell Endocrinol; 2015 Aug; 411():232-42. PubMed ID: 25958041
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combination therapy with irbesartan and efonidipine for attenuation of proteinuria in Dahl salt-sensitive rats.
    Takai S; Jin D; Sakonjo H; Miyazaki M
    Hypertens Res; 2010 Sep; 33(9):953-9. PubMed ID: 20520612
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A French cost-consequence analysis of the renoprotective benefits of irbesartan in patients with type 2 diabetes and hypertension.
    Palmer AJ; Valentine WJ; Tucker DM; Ray JA; Roze S; Annemans L; Lapuerta P; Chen R; Gabriel S; Carita P; Rodby RA; de Zeeuw D; Parving HH; Laville M
    Curr Med Res Opin; 2006 Nov; 22(11):2095-100. PubMed ID: 17076969
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of candesartan, an angiotensin II type 1 receptor blocker, on diabetic nephropathy in KK/Ta mice.
    Liao J; Kobayashi M; Kanamuru Y; Nakamura S; Makita Y; Funabiki K; Horikoshi S; Tomino Y
    J Nephrol; 2003; 16(6):841-9. PubMed ID: 14736011
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [IRMA-pRAcs: irbesartan in the treatment of microalbuminuria and proteinuria in patients with type 2 diabetes and hypertension-prospective observational study involving 38,016 patients in the general practice setting].
    Lehnert H; Bramlage P; Pittrow D; Kirch W
    MMW Fortschr Med; 2003 Oct; 145 Suppl 3():81-7. PubMed ID: 15490772
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mechanisms of irbesartan in prevention of renal lesion in streptozotocin-induced diabetic rats.
    Liu BC; Chen Q; Luo DD; Sun J; Phillips AO; Ruan XZ; Liu NF
    Acta Pharmacol Sin; 2003 Jan; 24(1):67-73. PubMed ID: 12511232
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes.
    Lewis EJ; Hunsicker LG; Clarke WR; Berl T; Pohl MA; Lewis JB; Ritz E; Atkins RC; Rohde R; Raz I;
    N Engl J Med; 2001 Sep; 345(12):851-60. PubMed ID: 11565517
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of integrin-linked kinase by angiotensin II receptor antagonist, irbesartan attenuates podocyte injury in diabetic rats.
    Dai HY; Zheng M; Tang RN; Ma KL; Ni J; Liu BC
    Chin Med J (Engl); 2012 Mar; 125(5):888-93. PubMed ID: 22490592
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Influence of irbesartan on renal hypertrophy and thickening of glomerular basement-membrane in streptozotocin-induced diabetic rats].
    Liu BC; Luo DD; Sun J; Ma KL; Ruan XZ
    Zhonghua Nei Ke Za Zhi; 2003 May; 42(5):320-3. PubMed ID: 12882713
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Independent and additive impact of blood pressure control and angiotensin II receptor blockade on renal outcomes in the irbesartan diabetic nephropathy trial: clinical implications and limitations.
    Pohl MA; Blumenthal S; Cordonnier DJ; De Alvaro F; Deferrari G; Eisner G; Esmatjes E; Gilbert RE; Hunsicker LG; de Faria JB; Mangili R; Moore J; Reisin E; Ritz E; Schernthaner G; Spitalewitz S; Tindall H; Rodby RA; Lewis EJ
    J Am Soc Nephrol; 2005 Oct; 16(10):3027-37. PubMed ID: 16120823
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Angiotensin II antagonists: clinical experience in the treatment of hypertension, prevention of cardiovascular outcomes and renal protection in diabetic nephropathy and proteinuria.
    Ribeiro AB; Gavras H
    Arq Bras Endocrinol Metabol; 2006 Apr; 50(2):327-33. PubMed ID: 16767299
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of xenogeneic transplantation of umbilical cord-derived mesenchymal stem cells combined with irbesartan on renal podocyte damage in diabetic rats.
    Meng J; Gao X; Liu X; Zheng W; Wang Y; Wang Y; Sun Z; Yin X; Zhou X
    Stem Cell Res Ther; 2024 Jul; 15(1):239. PubMed ID: 39080783
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Angiotensin II receptor blocker irbesartan attenuates cardiac dysfunction induced by myocardial infarction in the presence of renal failure.
    Watanabe R; Suzuki J; Wakayama K; Kumagai H; Ikeda Y; Akazawa H; Komuro I; Isobe M
    Hypertens Res; 2016 Apr; 39(4):237-44. PubMed ID: 26657004
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Irbesartan: a review of its use in hypertension and diabetic nephropathy.
    Croom KF; Plosker GL
    Drugs; 2008; 68(11):1543-69. PubMed ID: 18627212
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adding a statin to a combination of ACE inhibitor and ARB normalizes proteinuria in experimental diabetes, which translates into full renoprotection.
    Zoja C; Corna D; Gagliardini E; Conti S; Arnaboldi L; Benigni A; Remuzzi G
    Am J Physiol Renal Physiol; 2010 Nov; 299(5):F1203-11. PubMed ID: 20719975
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.